Skip to main content

Diagnostic Digest

  • November 11, 2026

    One Health, No Silos: Integrating Veterinary, Human, and Environmental Stewardship Strategies to Close the AMR Diagnostic Gap

    Explore how One Health strategies integrate human, veterinary, and environmental stewardship to close diagnostic gaps and combat antimicrobial resistance (AMR).

  • October 27, 2026

    Why Timing Matters as Much as Accuracy in Vaginitis Diagnostics

    Diagnostic accuracy is critical, but result timing also impacts vaginitis care. Learn how molecular testing may help clinicians make more informed treatment decisions during the patient visit.

  • September 10, 2026

    From the Minds at NASA to the Hands of Microbiologists: The Origins of VITEK® 2

    The VITEK® 2 story is a journey from the early questions of space-era microbiology to the everyday urgency of patient care. The technology inspired by the need to understand microbial growth beyond Earth now supports modern laboratories in clinical decision-making. 

  • September 03, 2026

    AMR Pathways S2E3: How Inpatient Stewardship Is Evolving Through Diagnostics, Data, and Collaboration

    Explore key insights from AMR Pathways S2E3 as Dr. Brittany Rodriguez discusses how inpatient antimicrobial stewardship is evolving through diagnostic stewardship, rapid diagnostics, data analytics, and multidisciplinary collaboration to improve patient care and optimize antibiotic use.
  • August 20, 2026

    Revolutionary Approach to Sepsis Treatment, Easy Integration: The Impact of VITEK® REVEAL™ on the Lab at Cincinnati Children’s Hospital

    See how Cincinnati Children's Hospital uses VITEK® REVEAL™ to reduce time to antimicrobial susceptibility results and support patient care.

  • August 06, 2026

    Centralized or decentralized? Choosing a testing workflow for today’s clinical microbiology lab

    Explore the benefits of centralized and decentralized clinical microbiology workflows. Learn how blood culture, ID/AST, and automation strategies can improve turnaround times, antimicrobial stewardship, and patient care.
  • July 13, 2026

    Cyclosporiasis: What You Need to Know About the Emerging Parasitic Infection

    Monitor the 2026 rise in Cyclospora infections, explore cyclosporiasis symptoms, and learn how BIOFIRE GI Panels support rapid detection and surveillance.

  • July 09, 2026

    Diagnose Confidently, Deescalate Earlier: The Value of Multiplex PCR for ED Respiratory Cases

    When an otherwise healthy patient presents to the emergency department (ED) with mild respiratory symptoms, the risks associated with empiric therapy is generally low. Immunocompromised patients, on the other hand, don’t have the luxury of uncertainty. For these at-risk individuals, a missed diagnosis or prolonged exposure to empiric antimicrobials may worsen outcomes.

  • July 07, 2026

    Diagnostic Stewardship & Molecular Assays: A Laboratorian’s Primer

    Diagnostic stewardship programs optimize laboratory testing, improve patient care, reduce unnecessary testing, and support value-based healthcare goals.

  • June 25, 2026

    Key Takeaways: Advancing Antimicrobial Stewardship in Outpatient Care

    Outpatient antimicrobial stewardship is a shared responsibility across healthcare disciplines. Whether you are a clinician, microbiologist, pharmacist, nurse, infection preventionist, or public health professional, small changes can have a meaningful impact.

  • June 04, 2026

    Local Health Monitor: Infectious Disease Insights for Smarter Healthcare Decisions

    The Local Health Monitor helps eliminate that uncertainty by delivering a comprehensive, data-driven view of infectious disease activity at the local level. Powered by the latest CDC data, this interactive dashboard helps healthcare teams anticipate patient volumes, optimize testing readiness, and respond with confidence. 

  • May 07, 2026

    The Value of Preventing Acute Kidney Injury for Cardiovascular Patients

    This article summarizes the findings of our “The Value of Preventing Acute Kidney Injury” Dossier, including the current burden of AKI for hospitals, where current risk assessment practices fall short, and how VIDAS® NEPHROCHECK® [TIMP-2 · IGFBP-7] from bioMérieux is designed to fill in the gaps.